Abstract
Background
Thrombocytosis is commonly associated with malignant disease and has recently been suggested to be a poor prognostic indicator in patients with lung cancer and gynecological cancers. The prevalence of thrombocytosis in patients with gastric cancer was reviewed, and its association with poor prognosis was investigated.
Methods
Platelet count (PLT) and hemoglobin concentrations (Hb) were reviewed in 369 consecutive patients with histologically verified gastric cancer from 1994 to 2000. Differences between categories were analyzed with analysis of variance, and survival was compared by using the log-rank test on the Kaplan-Meier life table. Multivariate Cox regression analysis was used to evaluate whether thrombocytosis is an independent prognostic marker.
Results
Thrombocytosis was found in 42 patients, and anemia was found in 200 patients. PLT was negatively correlated with Hb. Mean PLT was significantly increased in patients with noncurative operations. There was a positive correlation between the depth of tumor invasion and PLT. One- and 3-year survival expectancies in patients with or without thrombocytosis were 52.4% and 23.4% and 85.7% and 72.9%, respectively. PLT was identified as an independent prognostic factor after lymph node metastasis and depth of tumor invasion.
Conclusions
Thrombocytosis is an independent prognostic indicator of survival in patients with gastric cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Riess L. Zur Pathologischen Anaotmie des Blutes.Arch Anat Physiol Wissensch Med 1872;39:237–49.
Costantini V, Zacharski LR, Moritz TE, Edwards RL. The platelet count in carcinoma of the lung and colon.Thromb Haemost 1990; 64:501–5.
Symbas NP, Townsend MF, El GR, Keane TE, Graham SD, Petros JA. Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma.BJU Int 2000;86:203–7.
Rodriguez GC, Clarke PD, Soper JT, Berchuck A, Synan I, Dodge RK. The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer.Obstet Gynecol 1994;83:445–8.
Hernandez E, Donohue KA, Anderson LL, Heller PB, Stehman FB. The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study.Gynecol Oncol 2000;78:137–42.
Zeimet AG, Marth C, Muller HE, Daxenbichler G, Dapunt O. Significance of thrombocytosis in patients with epithelial ovarian cancer.Am J Obstet Gynecol 1994;170:549–54.
Hefler L, Mayerhofer K, Leibman B, et al. Tumor anemia and thrombocytosis in patients with vulvar cancer.Tumour Biol 2000; 21:309–14.
Hernandez E, Lavine M, Dunton CJ, Gracely E, Parker J. Poor prognosis associated with thrombocytosis in patients with cervical cancer.Cancer 1992;69:2975–7.
Jatzko GR, Lisborg PH, Denk H, Klimpfinger M, Stettner HM. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan.Cancer 1995;76:1302–12.
Stomach. In: American Joint Committee on Cancer.AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven, 1997:71–6.
Engan T, Hannisdal E. Blood analyses as prognostic factors in primary lung cancer.Acta Oncol 1990;29:151–4.
Pedersen LM, Milman N. Prognostic significance of thrombocytosis in patients with primary lung cancer.Eur Respir J 1996;9:1826–30.
Levin J, Conley C. Thrombocytosis associated with malignant disease.Arch Intern Med 1964;114:497–500.
Gucer F, Moser F, Tamussino K, et al. Thrombocytosis as a prognostic factor in endometrial carcinoma.Gynecol Oncol 1998;70:210–4.
Lidor YJ, Xu FJ, Martinez MO, et al. Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cells.Exp Cell Res 1993;207:332–9.
Kabir S, Daar GA. Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma.Cancer Lett 1995;95:207–12.
Wu CW, Wang SR, Chao MF, et al. Serum interleukin-6 levels reflect disease status of gastric cancer.Am J Gastroenterol 1996; 91:1417–22.
Nakazaki H. Preoperative and postoperative cytokines in patients with cancer.Cancer 1992;70:709–13.
Karpatkin S, Pearlstein E. Role of platelets in tumor cell metastasis.Ann Intern Med 1981;95:636–41.
Nieswandt B, Hafner M, Echtenacher B, Mannel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets.Cancer Res 1999;59:1295–300.
Kim YJ, Borsig L, Varki NM, Varki A. P-selectin deficiency attenuates tumor growth and metastasis.Proc Natl Acad Sci USA 1998;95:9325–30.
McCarty OJ, Mousa SA, Bray PF, Konstantopoulos K. Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions.Blood 2000;96:1789–97.
Tuszynski GP, Gasic TB, Rothman VL, Knudsen KA, Gasic GJ. Thrombospondin, a potentiator of tumor cell metastasis.Cancer Res 1987;47:4130–3.
Verheul HM, Hoekman K, Luykx-de Bakker S, et al. Platelet: transporter of vascular endothelial growth factor.Clin Cancer Res 1997;3:2187–90.
Poon RT, Fan S, Wong J. Clinical implications of circulating angiogenic factors in cancer patients.J Clin Oncol 2001;19:1207–25.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ikeda, M., Furukawa, H., Imamura, H. et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Annals of Surgical Oncology 9, 287–291 (2002). https://doi.org/10.1007/BF02573067
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02573067